Ingram Biosciences Private Limited - Company Profile

It is a pharma private limited company based in Noida, Uttar Pradesh, India, established in 2019.
2019 Noida, Uttar Pradesh, India Active
Last Updated:
Access Report
About Ingram Biosciences Private Limited

Ingram Biosciences Private Limited, a active private limited company, was established on 24 April 2019 in Noida, Uttar Pradesh, India. Engaging in drug formulation & development within the trade sector, it holds CIN: U24230UP2019PTC116200. Registered under ROC Roc Kanpur. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.

Its leadership includes Jeet Mala (Director), Sakshi (Director). Past directors included Vineet Khanna, Kul Bhushan Sharma, Jeet Mala. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 1203, 2Nd Floor, Ats Greens-2, Plot No A-58, Sector 50, Noida, Uttar Pradesh, 201301.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24230UP2019PTC116200

  • Registration Number

    116200

  • Incorporation Date

    24 April 2019

  • Authorized Capital

    ₹0.10 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Kanpur

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 6 Year, 9 Months
  • Last Filing with ROC 31 Mar 2024
  • Revenue Growth **** 67.31%
  • Profit Growth **** 32.26%
  • Ebitda **** -522.01%
  • Net Worth 48.23%
  • Total Assets **** 44.49%
Company report

Ingram Biosciences Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Ingram Biosciences Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Ingram Biosciences Private Limited?
Current Directors
Name Designation Appointment Date Status
Jeet Mala Director 31 Jul 2019 Current
Sakshi Director 05 Jan 2022 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 31 Jul 2019 Past
Pramod Abcsdd Director 31 Jul 2019 Past
Pramod Abcsdd Additional Director 30 Dec 2020 Past
Pramod Abcsdd Additional Director 30 Dec 2020 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Ingram Biosciences.

Ingram Biosciences Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 67.31% increase. The company also saw a substantial improvement in profitability, with a 32.26% increase in profit. The company's net worth Soared by an impressive increase of 48.23%.

Ingram Biosciences revenue growth over time
Ingram Biosciences profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 67.31%
*******
*******
*******
*******
Revenue from Operations
*******
 67.31%
*******
*******
*******
*******
Total Assets
*******
 44.49%
*******
*******
*******
*******
Profit or Loss
*******
 32.26%
*******
*******
*******
*******
Net Worth
*******
 48.23%
*******
*******
*******
*******
EBITDA
*******
 -522.01%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Ingram Biosciences?

Unlock access to Ingram Biosciences's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Ingram Biosciences?

Unlock and access historical data on people associated with Ingram Biosciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Ingram Biosciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ingram Biosciences's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Ingram Biosciences
Recent Activity within the Organization
  • Annual General Meeting

    Progress on Ingram Biosciences Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.

  • Balance Sheet

    Ingram Biosciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Kanpur. was recorded as a recent event.

  • Director Appointment

    Progress on Sakshi was appointed as a Director was appointed as a Director on 05 Jan 2022 & has been associated with this company since 4 years 1 month . was documented.

  • Director Appointment

    Progress on Jeet Mala was appointed as a Director was appointed as a Director on 31 Jul 2019 & has been associated with this company since 6 years 6 months . was documented.

  • Company Incorporation

    Ingram Biosciences Private Limited was registered on 24 Apr 2019 with Roc Kanpur & aged 6 years 9 months as per MCA records. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Ingram Biosciences Private Limited?

The CIN of Ingram Biosciences Private Limited is U24230UP2019PTC116200.

Where is Ingram Biosciences Private Limited headquartered?

Ingram Biosciences Private Limited is headquartered at 1203, 2Nd Floor, Ats Greens-2, Plot No A-58, Sector 50, Noida, Uttar Pradesh, 201301.

When was Ingram Biosciences Private Limited incorporated?

Ingram Biosciences Private Limited was incorporated on 24 April 2019.

Who are the current directors of Ingram Biosciences Private Limited?

The current directors of Ingram Biosciences Private Limited are

What is the primary industry of Ingram Biosciences Private Limited?

The primary industry of Ingram Biosciences Private Limited is Trade.

Is Ingram Biosciences Private Limited a listed company?

Ingram Biosciences Private Limited is unlisted.

What is the capital structure of Ingram Biosciences Private Limited?

The authorized capital of Ingram Biosciences Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available